Value of soluble adhesion molecules and plasma coagulation markers in assessing transplant coronary artery disease in pediatric heart transplant recipients

Pediatric Transplantation

Volumn 10, Issue 4, 2006, Pages 434-440

  Hilgendorff, Anne ^a   Kraemer, Ulrike ^a   Afsharian, Mehdi ^a   Bauer, Juergen ^a   Tillmanns, Harald ^a   Kemkes Matthes, Bettina ^a   Kreuder, Jochen ^a   Hoelschermann, Hans ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Adhesion molecules; Heart transplantation; Hemostasis; Transplant coronary artery disease

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; D DIMER; INTERCELLULAR ADHESION MOLECULE 1; PROTHROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ANGIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FISHER EXACT TEST; HEART GRAFT; HEART MUSCLE; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; INFANT; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECIPIENT; RELIABILITY; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; VENOUS BLOOD;

ADOLESCENT; ADULT; ANGIOGRAPHY; BIOLOGICAL MARKERS; BLOOD COAGULATION; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SOLUBILITY;

EID: 33646886644     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00488.x     Document Type: Article

References (19)

1. Costanzo MR, Eisen HJ, Brown RN, et al. Are there specific risk factors for fatal allograft vasculopathy? An analysis of over 7,000 cardiac transplant patients. J Heart Lung Transplant 2001 : 20 : 152.
2. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the international society for heart and lung transplantation : seventh official pediatric report - 2004. J Heart Lung Transplant 2004 : 23 : 933 947.
3. Pahl E, Naftel DC, Kuhn MA, et al. The impact and outcome of transplant coronary artery disease in a pediatric population. J Heart Lung Transplant 2005 : 24 : 645 651.
4. Richter M, Zahn S, Richter H, Mohr FW, Olbrich HG. Reduction of ICAM-1 and LFA-1-positive leukocytes in the perivascular space of arteries under mycophenolate mofetil therapy reduces rat heart transplant vasculopathy. J Heart Lung Transplant 2004 : 23 : 1405 1413.
5. Labarrere CA, Nelson DR, Park JW. Pathologic markers of allograft arteriopathy : insight into the pathophysiology of cardiac allograft chronic rejection. Curr Opin Cardiol 2001 : 16 : 110 117.
6. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography : a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac transplant research database. J Heart Lung Transplant 1998 : 17 : 744 753.
7. Putzer GJ, Cooper D, Keehn C, Asante-Korang A, Boucek MM, Boucek RJ, Jr.. An improved echocardiographic rejection-surveillance strategy following pediatric heart transplantation. J Heart Lung Transplant 2000 : 19 : 1166 1174.
8. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection : heart rejection study group. J Heart Transplant 1990 : 9 : 587 593.
9. Rudloff S, Thomas C, Kunz C. Variations of soluble intercellular cell adhesion molecule 1 (sICAM-1) in serum of adult volunteers. Eur J Med Res 1995 : 1 : 171 172.
10. Chin C, Naftel DC, Singh TP, et al. Risk factors for recurrent rejection in pediatric heart transplantation : a multicenter experience. J Heart Lung Transplant 2004 : 23 : 178 185.
11. Schenkel AR, Mamdouh Z, Muller WA. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 2004 : 5 : 393 400.
12. Holschermann H, Hilgendorff A, Kemkes-Matthes B, et al. Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients. Transplantation 2000 : 69 : 1830 1836.
13. Labarrere CA, Nelson DR, Miller SJ, et al. Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure. Circulation 2000 : 102 : 1549 1555.
14. Pethig K, Heublein B, Kutschka I, Haverich A. Systemic inflammatory response in cardiac allograft vasculopathy : high-sensitive C-reactive protein is associated with progressive luminal obstruction. Circulation 2000 : 102 19 Suppl. 3 : III233 III236.
15. Faulk WP, Labarrere CA, Nelson DR, Pitts D. Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis. J Heart Lung Transplant 1995 : 14 6 Partt 2 : S158 S164.
16. Holschermann H, Kohl O, Maus U, et al. Cyclosporin A inhibits monocyte tissue factor activation in cardiac transplant recipients. Circulation 1997 : 96 : 4232 4238.
17. Fan ST, Mackman N, Cui MZ, Edgington TS. Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains. J Immunol 1995 : 154 : 3266 3274.
18. Boucek MM, Faro A, Novick RJ, et al. The registry of the international society for heart and lung transplantation : fourth official pediatric report - 2000. J Heart Lung Transplant 2001 : 20 : 39 52.
19. Yamaura K, Ito K, Tsukioka K, et al. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation : induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 2004 : 110 : 1650 1657.